Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,3684,142,10.35 [3.95-27.08],1.9216881931033e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ABCA2,ATP-binding cassette sub-family A member 2,3553,138,2.12 [1.53-2.93],5.450243191221513e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACE,Angiotensin-converting enzyme,3685,143,2.30 [1.32-4.02],0.0034672244308359
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACP5,Tartrate-resistant acid phosphatase type 5,4256,174,1.80 [1.23-2.63],0.0024646165141979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACRV1,Acrosomal protein SP-10,3559,140,1.27 [1.09-1.48],0.0022656923892478
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",4152,167,1.97 [1.64-2.37],4.210487063963831e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,4187,169,6.11 [4.38-8.51],1.0582033295629727e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,4210,170,2.84 [2.26-3.58],4.910400637166584e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,3559,140,2.45 [1.75-3.43],1.6588057182902485e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,4194,169,2.56 [1.80-3.65],1.775450651772291e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,4281,174,2.26 [1.49-3.44],0.0001247543040237
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,4258,173,1.98 [1.31-3.00],0.0012805924971144
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,3652,139,3.44 [2.38-4.96],4.782476573151403e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,3559,140,2.40 [1.50-3.85],0.0002526888512418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,4212,172,1.57 [1.17-2.11],0.002547711061823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,4152,167,1.57 [1.15-2.16],0.005006577335868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,3559,140,1.74 [1.17-2.59],0.0062261399450455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,3683,141,2.28 [1.64-3.16],9.669109594495308e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,4187,169,3.03 [2.26-4.06],1.454780536626041e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,3611,140,2.35 [1.69-3.26],3.809043089264201e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE2,Adhesion G protein-coupled receptor E2,4248,170,3.57 [2.37-5.37],9.919154775317883e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRE5,Adhesion G protein-coupled receptor E5,4266,174,2.92 [2.10-4.06],2.00936908772484e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,4212,172,1.46 [1.31-1.63],4.762056341154922e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,4233,173,0.35 [0.22-0.55],7.615058671754151e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,4152,167,0.77 [0.65-0.89],0.0007590741538991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,4267,175,7.28 [4.51-11.75],4.489653239278832e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFM,Afamin,3684,142,0.38 [0.19-0.75],0.0053310450361052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AFP,Alpha-fetoprotein,4180,169,0.67 [0.54-0.83],0.0003445141097929
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGER,Advanced glycosylation end product-specific receptor,4222,170,1.58 [1.16-2.15],0.0033514339144537
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,4073,161,1.47 [1.30-1.67],1.7275438950545702e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,4096,164,1.42 [1.13-1.78],0.0026264814719457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,4248,170,3.02 [2.40-3.81],8.870337408528301e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,4281,174,1.99 [1.53-2.58],2.0725570105464454e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALCAM,CD166 antigen,4283,174,3.48 [1.97-6.15],1.7648679326381485e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ALDH2,"Aldehyde dehydrogenase, mitochondrial",3659,142,1.32 [1.10-1.58],0.0025029727130751
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,4263,175,14.08 [8.23-24.09],4.958418186025831e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMIGO2,Amphoterin-induced protein 2,4212,172,2.14 [1.25-3.68],0.0057366371430612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,4230,170,2.42 [1.72-3.41],3.503510996609926e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,4267,175,3.28 [2.48-4.35],1.3883784899233462e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,4242,170,3.41 [2.58-4.50],7.266809969125758e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL7,Angiopoietin-related protein 7,4267,175,1.98 [1.47-2.66],7.050846650728376e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANXA5,Annexin A5,4090,164,2.41 [1.80-3.22],4.054273223758917e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,4246,171,5.60 [3.79-8.28],5.261247623636739e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA2,Apolipoprotein A-II,3685,143,1.55 [1.15-2.08],0.0034869490265885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,3684,142,3.11 [2.22-4.36],4.6789595337729313e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOD,Apolipoprotein D,3531,134,0.48 [0.29-0.79],0.0040595842501492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,4246,172,1.58 [1.14-2.20],0.0060577805779814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOM,Apolipoprotein M,4245,171,0.55 [0.35-0.85],0.0079102873622468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,4212,172,2.63 [2.11-3.28],8.974926953758164e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ARNT,Aryl hydrocarbon receptor nuclear translocator,4131,169,1.42 [1.12-1.81],0.0041799794586272
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ART3,Ecto-ADP-ribosyltransferase 3,4246,171,2.04 [1.47-2.82],1.7480776448210826e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,4194,169,3.79 [2.74-5.23],6.831784698226689e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,3685,143,4.71 [2.96-7.50],6.552271584901333e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,3670,144,2.17 [1.37-3.44],0.0008947122852807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,3652,139,3.14 [2.26-4.38],1.2954522675369656e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AXL,Tyrosine-protein kinase receptor UFO,4246,171,1.83 [1.17-2.86],0.0078277168833182
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,3684,142,3.41 [2.41-4.82],3.9213802514040306e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",3579,143,3.91 [2.57-5.93],1.5436464383190787e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",4248,170,4.38 [2.88-6.66],4.966422245451969e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,4103,164,1.36 [1.14-1.62],0.0006488119397979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,4103,164,2.67 [2.04-3.49],1.037851166803958e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,4246,172,3.67 [2.21-6.08],4.830577677610631e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAN,Brevican core protein,4194,169,0.62 [0.43-0.89],0.0097920293051713
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",4226,172,2.19 [1.51-3.18],3.467063344566498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,3611,140,2.46 [1.58-3.81],6.017436991959635e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,3611,140,3.27 [2.07-5.16],3.858193151310783e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,4152,167,3.40 [1.97-5.87],1.0761158385351691e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,4273,174,5.75 [3.61-9.16],1.6205831314893074e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,4264,173,2.67 [1.71-4.18],1.7221236717763467e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTD,Biotinidase,3684,142,3.04 [1.38-6.68],0.0057681902013028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,4248,170,4.65 [3.45-6.29],1.1721080196790037e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,4226,172,2.56 [1.86-3.52],6.726349022074502e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,3553,138,1.55 [1.17-2.04],0.00208467885971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QA,Complement C1q subcomponent subunit A,4259,174,2.95 [1.73-5.02],6.88354466980667e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,4246,171,1.80 [1.43-2.27],7.455805371147368e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C2,Complement C2,4245,171,2.68 [1.36-5.29],0.0044438435577388
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C7,Complement component C7,3587,139,3.34 [2.27-4.91],9.748481029765884e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,4212,172,3.63 [2.90-4.54],1.3168429748001519e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA14,Carbonic anhydrase 14,4267,175,2.07 [1.51-2.83],4.967492059820758e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA3,Carbonic anhydrase 3,4279,174,1.43 [1.17-1.75],0.0004722709054274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,4283,174,2.20 [1.35-3.59],0.0016221981208028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA6,Carbonic anhydrase 6,4231,170,0.74 [0.60-0.91],0.0040537804935206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA9,Carbonic anhydrase 9,4267,175,1.65 [1.33-2.04],6.497586487990573e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,4212,172,2.03 [1.55-2.66],2.5380431151822373e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,4101,164,2.66 [1.83-3.86],3.220928607924936e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCA,Calcitonin,4185,168,1.48 [1.25-1.76],4.658161953047669e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALCB,Calcitonin gene-related peptide 2,3657,142,1.78 [1.43-2.21],2.061322150978726e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CANT1,Soluble calcium-activated nucleotidase 1,4217,171,2.74 [1.48-5.10],0.0014120687110784
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,4233,173,1.43 [1.22-1.66],5.835772940479065e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,4267,175,0.60 [0.41-0.88],0.0085072040642371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,4233,173,1.77 [1.28-2.46],0.0006125450776702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL11,Eotaxin,4281,174,2.40 [1.72-3.37],3.257272583489734e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,4230,170,2.55 [1.97-3.30],8.963779262848946e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,4283,174,2.38 [1.88-3.03],1.151717238977628e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,4283,174,1.67 [1.30-2.16],7.378252513718354e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL21,C-C motif chemokine 21,4248,170,1.57 [1.29-1.91],8.057182385269948e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL23,C-C motif chemokine 23,4248,170,1.48 [1.10-2.00],0.0089384955069356
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,4281,174,1.92 [1.47-2.50],1.2433827986295944e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,4226,172,1.35 [1.20-1.53],1.2970793430152652e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL7,C-C motif chemokine 7,4226,172,1.37 [1.10-1.71],0.0043624167068334
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,4269,174,2.90 [2.18-3.84],1.6965695543940757e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,4267,175,3.09 [2.35-4.06],5.194159730445726e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,4246,172,2.95 [2.20-3.97],6.8084578693521e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD109,CD109 antigen,4246,172,1.97 [1.35-2.87],0.0004351401923848
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD14,Monocyte differentiation antigen CD14,4164,165,2.63 [1.98-3.49],1.8457479254917208e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,4281,174,2.24 [1.79-2.80],1.7859263032633688e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,4246,172,1.69 [1.38-2.07],3.209224120507883e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD200,OX-2 membrane glycoprotein,4226,172,2.55 [1.77-3.67],4.437386159062227e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,4143,170,2.43 [1.78-3.33],2.9004733336086204e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD244,Natural killer cell receptor 2B4,4281,174,2.20 [1.44-3.37],0.0002959859453731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,4238,174,3.48 [2.81-4.32],4.6054470687920525e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD274,Programmed cell death 1 ligand 1,4194,169,2.25 [1.72-2.95],4.140859709069515e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,4226,170,5.18 [3.86-6.96],9.036525005661602e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD28,T-cell-specific surface glycoprotein CD28,4103,164,2.16 [1.59-2.94],8.945350812722201e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300A,CMRF35-like molecule 8,3611,140,2.72 [1.68-4.39],4.500040567228181e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,4264,173,3.63 [2.60-5.07],3.532010663999403e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,4254,175,2.67 [2.07-3.43],3.63558119585792e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LF,CMRF35-like molecule 1,4267,175,1.66 [1.32-2.09],1.5288508955528523e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,4246,172,2.58 [1.89-3.51],1.899901106982033e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,4212,172,3.57 [2.70-4.74],8.587266020233864e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,4212,172,2.36 [1.66-3.36],1.859886747969565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD4,T-cell surface glycoprotein CD4,4219,170,2.55 [1.88-3.47],2.4151687896371446e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD40,Tumor necrosis factor receptor superfamily member 5,4232,170,1.48 [1.17-1.86],0.0010509654070089
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD46,Membrane cofactor protein,4213,169,3.15 [2.21-4.47],1.7666546644220512e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD48,CD48 antigen,4242,170,3.39 [2.24-5.13],7.1691859020422445e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,4263,175,2.53 [1.94-3.31],1.158056778105554e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,4083,164,3.18 [2.22-4.57],3.306162642435575e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,4074,170,4.49 [3.17-6.36],3.2845769274036655e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD7,T-cell antigen CD7,3549,140,1.99 [1.47-2.69],8.622924125408107e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD70,CD70 antigen,4226,172,1.51 [1.12-2.03],0.0068186582789226
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD72,B-cell differentiation antigen CD72,3611,140,1.80 [1.29-2.52],0.0005310376335298
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,4264,173,4.81 [3.53-6.55],1.8195230741123494e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,4281,174,2.48 [1.98-3.11],3.2775071477312e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,3670,144,2.77 [1.91-4.02],8.853063264449633e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,4226,172,2.65 [1.94-3.62],1.0001069870492108e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,4090,159,2.85 [1.98-4.08],1.2628719543197724e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99,CD99 antigen,4246,172,4.94 [2.76-8.86],8.021481163359733e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD99L2,CD99 antigen-like protein 2,4246,172,3.36 [2.04-5.53],1.9434911776665355e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDCP1,CUB domain-containing protein 1,4194,169,1.35 [1.09-1.68],0.005692395668449
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,4083,165,2.22 [1.81-2.71],1.0463823557319922e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,4255,172,1.27 [1.09-1.47],0.0021242172156093
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH17,Cadherin-17,4233,173,1.44 [1.21-1.71],2.823174873940837e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH2,Cadherin-2,4233,173,1.58 [1.14-2.19],0.0057882960010788
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,4264,173,2.90 [2.18-3.87],2.6936027210725674e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH6,Cadherin-6,4233,173,1.79 [1.31-2.43],0.0002295782876595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,4212,172,1.70 [1.39-2.07],1.706016784360182e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,4262,174,1.67 [1.26-2.22],0.0003701923430789
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,4055,159,1.42 [1.16-1.73],0.0007974706944779
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,3611,140,2.21 [1.33-3.66],0.002165488036658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,3536,140,1.56 [1.18-2.07],0.0018377495067246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,4212,172,1.54 [1.25-1.90],5.168649310401641e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,4103,164,1.49 [1.19-1.86],0.0005201858137505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFD,Complement factor D,3684,142,4.01 [2.49-6.46],1.2140501001097324e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGA,Glycoprotein hormones alpha chain,4246,172,1.51 [1.28-1.79],9.935158555401543e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,4233,173,2.48 [1.92-3.20],3.2379534462582965e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,3611,140,0.49 [0.36-0.65],1.1647039699327696e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",3657,142,2.86 [2.14-3.83],1.4797678027165496e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,3659,142,1.67 [1.21-2.30],0.0016197363884996
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,3683,141,1.41 [1.26-1.59],4.639162299330549e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,4246,172,2.72 [2.12-3.48],3.2009683185602097e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,4132,166,1.59 [1.39-1.82],2.3827626395905918e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,4242,170,4.69 [3.31-6.66],4.668148506827997e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CILP,Cartilage intermediate layer protein 1,3683,141,1.89 [1.42-2.51],1.3342966789866712e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,4264,174,3.53 [2.81-4.44],2.514332130224722e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,3683,141,2.01 [1.60-2.51],1.0651859049070402e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,4194,169,2.36 [1.64-3.41],4.487073681460495e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,4246,172,3.31 [2.35-4.66],8.999560952815424e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC1A,C-type lectin domain family 1 member A,4152,167,2.27 [1.63-3.16],1.2994337439457795e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,3595,139,0.30 [0.16-0.57],0.0002572575090257
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,4226,172,0.61 [0.43-0.86],0.0049789596191523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4D,C-type lectin domain family 4 member D,4226,172,1.50 [1.24-1.82],3.228233558923956e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,4224,173,2.40 [1.65-3.49],4.4756859597177145e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC6A,C-type lectin domain family 6 member A,4103,164,1.52 [1.17-1.97],0.0014751981886071
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,4281,174,1.93 [1.48-2.51],1.0655229456123592e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,4267,175,6.32 [3.98-10.03],5.138972609827839e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN2,Calsyntenin-2,4281,174,1.84 [1.45-2.35],7.420183689707415e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN1,Contactin-1,4283,174,1.94 [1.21-3.12],0.0058378300336131
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN2,Contactin-2,4267,175,1.51 [1.14-2.00],0.0036766543832646
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN4,Contactin-4,4246,172,2.09 [1.22-3.56],0.0072122756266783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTNAP2,Contactin-associated protein-like 2,4226,172,1.61 [1.22-2.11],0.0007221922625052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,4244,172,8.80 [5.61-13.80],2.5382848925997018e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,3652,139,1.51 [1.13-2.03],0.0060181730013457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,4233,173,1.98 [1.57-2.51],1.0241171563608792e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL5A1,Collagen alpha-1(V) chain,3611,140,1.56 [1.21-2.01],0.0005624041501492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,4283,174,3.83 [2.98-4.93],1.9647246109652329e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,4226,170,6.02 [4.26-8.51],3.0656955007800664e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPA2,Carboxypeptidase A2,4251,171,1.37 [1.16-1.61],0.0001926721676259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,4242,173,2.39 [1.68-3.40],1.1998451343811906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPQ,Carboxypeptidase Q,3680,141,1.97 [1.29-3.02],0.0018271849850322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPVL,Probable serine carboxypeptidase CPVL,4260,174,1.91 [1.35-2.68],0.0002158853792577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPXM2,Inactive carboxypeptidase-like protein X2,3670,144,4.62 [2.79-7.65],2.514515053408279e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR1,Complement receptor type 1,3674,142,1.78 [1.17-2.69],0.0070011410735721
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CR2,Complement receptor type 2,4246,171,1.51 [1.16-1.97],0.0023094591167821
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,3611,140,2.56 [1.72-3.82],3.5719449757025904e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD2,Protein disulfide isomerase CRELD2,4242,170,1.39 [1.10-1.76],0.005685331669493
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRHBP,Corticotropin-releasing factor-binding protein,4226,170,2.44 [1.52-3.91],0.0002207245699173
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIM1,Cysteine-rich motor neuron 1 protein,4248,170,8.45 [4.95-14.43],5.716679811870309e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,4194,169,2.07 [1.55-2.77],7.637807596943612e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRLF1,Cytokine receptor-like factor 1,4248,170,2.57 [1.54-4.29],0.0003174120462029
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRTAM,Cytotoxic and regulatory T-cell molecule,4194,169,1.58 [1.22-2.05],0.0005148110629393
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,4248,170,4.22 [2.83-6.31],2.094669313059391e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,3685,143,1.69 [1.19-2.40],0.003430633921654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,4194,169,1.36 [1.11-1.66],0.0031585412657166
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSPG4,Chondroitin sulfate proteoglycan 4,3683,141,2.51 [1.61-3.93],5.426287991188005e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,4230,170,3.99 [2.87-5.55],1.8502848748759504e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST5,Cystatin-D,4156,168,1.45 [1.15-1.83],0.0017792020865878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST6,Cystatin-M,4114,171,1.48 [1.15-1.91],0.0022339435276106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,4178,167,1.75 [1.30-2.36],0.000239967447191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTHRC1,Collagen triple helix repeat-containing protein 1,3683,141,2.44 [1.57-3.80],7.736532385578128e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,4230,170,0.70 [0.59-0.83],3.277048403725768e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,3657,142,0.70 [0.58-0.84],0.0001477476344878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSB,Cathepsin B,4233,174,1.88 [1.49-2.36],7.745163357215007e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSD,Cathepsin D,3971,156,1.46 [1.10-1.95],0.0093811051491993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,3611,140,1.70 [1.29-2.24],0.000148805406949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSL,Cathepsin L1,4233,173,2.23 [1.38-3.59],0.0010581332639792
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSO,Cathepsin O,4281,174,2.51 [1.72-3.66],1.7185747974883777e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,3342,138,3.40 [1.80-6.40],0.0001548432742745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,4235,171,2.89 [2.00-4.17],1.7652113017628686e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,4194,169,2.97 [2.17-4.06],8.888575986827284e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXADR,Coxsackievirus and adenovirus receptor,4226,172,1.83 [1.45-2.31],3.523374015751588e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,4279,174,4.63 [2.87-7.48],3.87960327881142e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL6,C-X-C motif chemokine 6,4281,174,1.29 [1.09-1.53],0.0034188061492389
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,4196,174,1.30 [1.12-1.51],0.0005554355370134
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,4248,170,1.51 [1.27-1.79],2.8214892258492494e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DAG1,Dystroglycan,4248,170,1.54 [1.15-2.06],0.004018395671456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",4238,174,3.44 [2.45-4.82],8.439464628151607e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,4152,167,4.93 [3.04-8.00],1.06449059589013e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",4212,172,1.50 [1.13-1.98],0.0043792548828529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDR1,Epithelial discoidin domain-containing receptor 1,4264,173,4.14 [2.64-6.48],5.859949935709154e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFA1_DEFA1B,Neutrophil defensin 1,4136,166,1.73 [1.43-2.09],1.4012788201804129e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK3,Dickkopf-related protein 3,4283,174,3.24 [2.13-4.93],4.178996117075013e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,4189,169,2.60 [2.12-3.20],1.2394832742936375e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,4238,174,5.32 [3.86-7.33],1.4170126904356695e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMD,Dystrophin,3579,143,1.49 [1.15-1.93],0.0025268150643154
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,3579,143,0.54 [0.44-0.66],7.150468838647121e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,4212,172,2.51 [1.81-3.47],2.7587731255101534e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPT,Dermatopontin,4283,174,2.30 [1.33-3.97],0.0028242330828677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPY30,Protein dpy-30 homolog,4254,175,1.46 [1.21-1.77],0.0001048346073618
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,4194,169,2.04 [1.52-2.74],1.9577947714821577e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,4202,169,2.66 [2.20-3.22],1.0278376086193593e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG2,Desmoglein-2,4246,172,2.91 [1.94-4.35],2.114950631416475e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,4195,171,0.55 [0.42-0.73],2.2029799399185446e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTNB,Dystrobrevin beta,3653,141,2.02 [1.52-2.67],9.788360540736175e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DTX3,Probable E3 ubiquitin-protein ligase DTX3,4212,172,3.24 [2.06-5.10],3.783262981864189e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DYNLT3,Dynein light chain Tctex-type 3,3659,142,0.54 [0.37-0.79],0.0017128214124956
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EBI3_IL27,Interleukin-27,4259,175,3.18 [2.16-4.68],4.649557340963526e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,4267,175,3.75 [3.08-4.58],6.995284690445946e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,3579,143,3.86 [2.47-6.02],2.8079371806555237e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,3652,139,3.56 [2.45-5.17],2.390067001888016e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,4242,171,4.05 [2.89-5.66],3.047350280804764e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,3668,142,2.03 [1.45-2.85],4.25450788597138e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,4242,172,5.15 [3.79-6.99],8.278772650889956e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,4187,169,5.24 [4.05-6.79],4.223833924118033e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EGFL7,Epidermal growth factor-like protein 7,4103,164,2.09 [1.53-2.84],2.9757263243141814e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,3670,144,2.99 [2.02-4.43],4.352493198597511e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENDOU,Poly(U)-specific endoribonuclease,3380,127,1.54 [1.16-2.04],0.0030293414546876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENG,Endoglin,4283,174,3.51 [1.74-7.11],0.0004722860531598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENO3,Beta-enolase,3579,143,0.70 [0.54-0.92],0.0098728557108287
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENOPH1,Enolase-phosphatase E1,3659,142,0.63 [0.48-0.83],0.0010448895748959
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,4283,174,1.77 [1.16-2.72],0.0088046360303124
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,4152,167,2.82 [1.56-5.09],0.0005664779295274
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA1,Ephrin type-A receptor 1,4240,170,2.51 [1.68-3.74],6.06168595644915e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,4074,166,3.95 [3.07-5.07],5.814250233249839e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA4,Ephrin type-A receptor 4,3611,140,2.26 [1.33-3.86],0.0027142207110965
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,4283,174,5.22 [3.77-7.24],2.4054538377149445e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,4185,168,3.23 [2.30-4.55],1.7464003957923847e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,4226,172,1.25 [1.08-1.45],0.0029689668094872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB3,Receptor tyrosine-protein kinase erbB-3,4217,170,2.94 [1.57-5.49],0.0007168196259277
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,4238,174,2.39 [1.59-3.59],2.79355537376044e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ERMAP,Erythroid membrane-associated protein,3559,140,2.03 [1.44-2.86],5.212071072079594e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,4283,174,3.40 [2.45-4.71],2.819784064480663e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EXTL1,Exostosin-like 1,3553,138,1.43 [1.12-1.82],0.0036633976011258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F2R,Proteinase-activated receptor 1,4242,170,1.62 [1.28-2.06],6.13438712475938e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,F3,Tissue factor,4240,175,2.49 [1.62-3.82],2.952610133171234e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",4226,170,1.52 [1.34-1.72],3.673244707094856e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",4233,173,1.39 [1.20-1.60],8.226063384364901e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",3670,144,2.36 [1.91-2.91],8.573240605924789e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",4283,174,2.12 [1.76-2.55],1.0533933458671973e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,4254,172,1.40 [1.15-1.70],0.0008531938788862
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,4212,172,3.32 [2.36-4.66],4.160445723492624e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,4233,173,5.44 [3.93-7.54],1.946082953544946e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,3652,139,1.53 [1.28-1.84],4.755289415899016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAS,Tumor necrosis factor receptor superfamily member 6,4273,174,1.84 [1.46-2.32],2.707517705277771e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FBLN2,Fibulin-2,3683,141,2.39 [1.59-3.60],3.188089454191457e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCAR,Immunoglobulin alpha Fc receptor,4226,172,1.52 [1.20-1.92],0.0005519431649785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,4246,172,1.56 [1.28-1.91],1.3450332236932696e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,3681,143,2.00 [1.44-2.79],4.231553065051634e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL2,Fc receptor-like protein 2,4261,172,1.38 [1.10-1.75],0.0064091636858126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRL6,Fc receptor-like protein 6,4226,172,1.37 [1.12-1.67],0.0021714518557251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCRLB,Fc receptor-like B,4103,164,1.41 [1.17-1.71],0.0003777170500453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF16,Fibroblast growth factor 16,3559,140,0.53 [0.36-0.79],0.0020211231961314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,4259,175,1.24 [1.12-1.37],3.474286538362427e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,4256,175,1.64 [1.42-1.89],1.5993355583764977e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,4131,169,2.77 [2.14-3.59],1.2049867746250711e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,4238,174,0.46 [0.34-0.63],1.2310016433869556e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP2,Fibroblast growth factor-binding protein 2,3683,141,0.55 [0.40-0.75],0.0001982354052823
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,4238,174,3.95 [2.69-5.80],2.147425187269592e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,3685,143,1.68 [1.34-2.10],8.126127094799687e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,4194,169,3.21 [2.21-4.67],1.0183305062680803e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,4207,172,1.91 [1.28-2.85],0.0014750185004635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,4281,174,1.76 [1.21-2.57],0.0032214146572088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,4220,174,3.25 [2.27-4.66],1.3430720730003588e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR2,Folate receptor beta,4264,173,1.97 [1.28-3.04],0.0019928161768385
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL1,Follistatin-related protein 1,3579,143,4.55 [2.41-8.59],3.0122214093710506e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,4225,170,3.85 [2.91-5.10],6.165444284965464e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,4264,173,1.79 [1.36-2.36],3.725219647462877e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,4212,172,2.35 [1.51-3.66],0.0001593854752562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,4131,169,1.70 [1.28-2.28],0.0003042188523763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAS6,Growth arrest-specific protein 6,4260,174,2.32 [1.39-3.86],0.0012105895651796
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GAST,Gastrin,3657,142,1.17 [1.07-1.29],0.000626942849737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,4103,164,1.25 [1.13-1.39],3.10583576175063e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,3514,136,1.42 [1.09-1.85],0.0097914140297943
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",4212,172,2.27 [1.58-3.24],8.076192900747339e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,4283,174,2.66 [2.27-3.12],4.954033740236371e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDNF,Glial cell line-derived neurotrophic factor,4101,164,1.89 [1.40-2.54],2.747914447168167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,4259,175,6.02 [4.25-8.53],5.26088887016941e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,4184,168,2.87 [1.87-4.41],1.4846239719712969e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,4194,169,6.07 [4.01-9.18],1.2343125974098359e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GHR,Growth hormone receptor,3611,140,0.39 [0.23-0.66],0.0005507883521838
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,3657,142,2.87 [1.90-4.33],5.32104775474519e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GM2A,Ganglioside GM2 activator,3602,139,2.58 [1.97-3.38],4.6415601704344796e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GOLM2,Protein GOLM2,4264,173,2.12 [1.52-2.96],9.141629843843338e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,4212,172,0.85 [0.77-0.94],0.0025754200878701
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPC1,Glypican-1,4267,175,1.75 [1.15-2.68],0.0096766284199281
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPNMB,Transmembrane glycoprotein NMB,4131,168,2.63 [1.69-4.10],1.970084439091433e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,4152,167,2.37 [1.96-2.87],6.381019060986228e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,3659,142,1.50 [1.22-1.85],0.000132152099863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,4225,172,3.60 [2.19-5.91],4.0773655190102093e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",4212,172,1.34 [1.11-1.63],0.0028690682323215
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,4226,172,2.79 [2.13-3.67],1.4768001776272669e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,4263,175,2.11 [1.85-2.40],4.802026284051896e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,4246,172,3.03 [2.23-4.10],1.135799242247847e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBQ1,Hemoglobin subunit theta-1,4267,175,0.74 [0.59-0.92],0.0084966960300344
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEPH,Hephaestin,3670,144,5.35 [2.96-9.66],2.656726842809372e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HJV,Hemojuvelin,3668,142,1.54 [1.16-2.06],0.0031128432586208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",3668,142,2.43 [1.48-4.01],0.0004831586024373
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",4226,172,3.11 [2.31-4.20],1.1940535202691984e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,4175,168,1.39 [1.10-1.77],0.0062112695504559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,3579,143,1.82 [1.36-2.44],5.995402844403024e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,3559,140,1.83 [1.28-2.61],0.0008725185659845
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPA2,Heat shock-related 70 kDa protein 2,3659,142,1.97 [1.48-2.61],2.7856551804093565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,4267,175,3.03 [2.34-3.92],2.9983691772706924e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,4208,169,3.85 [2.85-5.20],1.3334231484162334e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,4199,167,3.63 [2.31-5.70],2.315611248083237e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYOU1,Hypoxia up-regulated protein 1,4283,174,4.86 [2.95-8.02],5.40381906499098e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM1,Intercellular adhesion molecule 1,4218,170,1.91 [1.29-2.83],0.0011762671227472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM2,Intercellular adhesion molecule 2,4283,174,2.99 [1.98-4.52],1.9741462195323373e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM3,Intercellular adhesion molecule 3,4283,174,1.95 [1.24-3.06],0.0039770607387831
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICOSLG,ICOS ligand,4212,172,2.52 [1.31-4.86],0.0057145529626217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDI2,Isopentenyl-diphosphate delta-isomerase 2,4101,164,1.43 [1.13-1.80],0.0027832543952468
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IDUA,Alpha-L-iduronidase,4267,175,1.61 [1.19-2.17],0.0017815129343238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,3556,131,1.83 [1.21-2.76],0.0041409081752239
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNGR1,Interferon gamma receptor 1,4248,170,5.57 [3.38-9.19],1.5969799909329084e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IFNL1,Interferon lambda-1,4101,164,1.44 [1.16-1.81],0.0012450775462141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,4212,172,6.49 [4.26-9.89],2.9750728404209813e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF2R,Cation-independent mannose-6-phosphate receptor,4246,172,2.45 [1.42-4.23],0.0012988732773776
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,4279,174,1.31 [1.18-1.46],6.611060928092401e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,4276,174,1.95 [1.63-2.34],2.688346592695402e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,4246,171,0.52 [0.39-0.70],8.836927318517066e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,4191,166,2.66 [2.21-3.21],4.8160089569927335e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,4223,170,2.76 [2.10-3.63],3.1784577880766134e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,4283,174,2.73 [2.13-3.51],3.0350459390125053e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,4233,173,2.39 [1.81-3.16],9.477193234668471e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF3,Immunoglobulin superfamily member 3,4212,172,1.58 [1.21-2.06],0.0007927491524371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,4233,173,2.17 [1.64-2.87],5.655148015905752e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,4131,169,1.26 [1.09-1.45],0.0014178827500199
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,4248,170,4.13 [2.87-5.96],3.075769565121867e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,4212,172,1.36 [1.17-1.58],8.146535166118813e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,4281,174,1.55 [1.23-1.94],0.0001740973564224
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12RB1,Interleukin-12 receptor subunit beta-1,4131,169,1.81 [1.28-2.55],0.0007725452861872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15,Interleukin-15,4226,172,2.15 [1.57-2.95],1.7871620588040672e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,4131,169,2.19 [1.55-3.09],9.46924444882016e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17C,Interleukin-17C,4131,169,1.39 [1.21-1.61],7.111843195644598e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,4131,169,1.54 [1.21-1.97],0.0005067718371868
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,4216,170,1.87 [1.42-2.48],9.2330889209339e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,4246,171,3.30 [2.37-4.60],1.3835801654335804e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18R1,Interleukin-18 receptor 1,4281,174,2.71 [1.94-3.79],4.915027510597008e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,4137,167,1.28 [1.10-1.48],0.0013860408846893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1R1,Interleukin-1 receptor type 1,4242,172,6.80 [4.51-10.24],4.6165135317067815e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,4273,174,1.95 [1.47-2.59],4.392994921509961e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,4208,171,2.46 [1.92-3.16],1.4540746513901973e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RG,Cytokine receptor common subunit gamma,3659,142,1.44 [1.11-1.86],0.0064164774913475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL4R,Interleukin-4 receptor subunit alpha,4226,172,2.53 [1.92-3.33],3.599145088373297e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL6ST,Interleukin-6 receptor subunit beta,4233,173,4.81 [2.39-9.67],1.0264825417847482e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,3659,142,1.56 [1.19-2.06],0.0015397778508559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,3611,140,2.48 [1.94-3.15],2.0494975866671402e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL4,Early placenta insulin-like peptide,3659,142,1.76 [1.44-2.15],4.0645348725708034e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSL5,Insulin-like peptide INSL5,3652,139,1.24 [1.07-1.45],0.0046609668897598
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,3559,140,6.03 [2.71-13.40],1.0283977650306917e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA5,Integrin alpha-5,4246,172,2.21 [1.41-3.47],0.0005901558163123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB1,Integrin beta-1,4229,171,2.12 [1.23-3.67],0.007165114465893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB2,Integrin beta-2,4215,170,1.75 [1.16-2.65],0.0081393406482005
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGB6,Integrin beta-6,4131,169,2.48 [1.61-3.80],3.261806094208792e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGBL1,Integrin beta-like protein 1,3683,141,1.82 [1.43-2.33],1.471661635715846e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,4246,171,2.64 [1.85-3.76],7.495744969993955e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,4264,173,5.11 [3.68-7.09],2.296467932135694e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JUN,Transcription factor AP-1,4131,169,1.39 [1.16-1.66],0.0004413367789032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,4212,172,1.95 [1.45-2.63],8.927116100929903e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIF1C,Kinesin-like protein KIF1C,3553,138,1.93 [1.29-2.88],0.0012578223991714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,3659,142,1.27 [1.07-1.50],0.0059610696606949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,4225,174,1.77 [1.31-2.38],0.0001739395862086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,4192,173,3.51 [2.67-4.60],1.2373573387605265e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK14,Kallikrein-14,4267,175,1.49 [1.13-1.96],0.0047924962673947
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,4267,175,2.05 [1.78-2.37],1.1342088306166241e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK6,Kallikrein-6,4232,174,2.25 [1.54-3.30],3.097107356976763e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK8,Kallikrein-8,4078,170,1.73 [1.25-2.40],0.0010060697937483
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,4281,174,3.12 [2.35-4.14],3.225129490631056e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,4281,174,1.70 [1.29-2.24],0.0001712425657453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,3559,140,1.44 [1.15-1.81],0.0017816136985221
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRK1,NKG2-D type II integral membrane protein,3657,142,1.65 [1.17-2.33],0.0043992119124024
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",4218,172,1.76 [1.51-2.06],1.0552648036491202e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KYNU,Kynureninase,4281,174,0.68 [0.52-0.88],0.0033888049568175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,4212,172,2.01 [1.64-2.47],2.2114144670463048e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,4226,170,2.57 [2.13-3.09],1.809242571787549e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMA4,Laminin subunit alpha-4,4248,170,1.96 [1.37-2.80],0.0002363689764791
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMB1,Laminin subunit beta-1,3579,143,2.00 [1.22-3.28],0.0058253088381302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAMP3,Lysosome-associated membrane glycoprotein 3,4273,174,1.46 [1.14-1.87],0.0023999289978464
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,4185,168,3.92 [3.07-5.00],6.324302904536225e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,3668,142,1.51 [1.30-1.76],1.3684135716668004e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,4106,166,2.20 [1.73-2.78],6.516425302602424e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,3670,144,1.37 [1.12-1.69],0.0023049789745172
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEFTY2,Left-right determination factor 2,4259,175,1.41 [1.10-1.80],0.00617722411731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LEPR,Leptin receptor,4233,173,1.69 [1.14-2.51],0.0086076643221011
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,4233,173,1.87 [1.32-2.63],0.000365348595214
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,4233,171,2.64 [1.76-3.97],2.9801780782703875e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,4226,170,2.32 [1.92-2.81],2.408778742611657e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS7_LGALS7B,Galectin-7,4224,172,1.58 [1.20-2.08],0.0010313460126863
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,4232,170,3.76 [2.59-5.45],3.6068516120608538e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,4226,172,6.19 [4.32-8.86],2.4400399008829362e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,4233,173,1.86 [1.23-2.82],0.0032238963232599
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,4131,169,2.34 [1.79-3.06],5.759705343273983e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMNB2,Lamin-B2,3657,142,2.33 [1.51-3.61],0.0001431861893603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,3668,142,2.68 [2.06-3.48],2.1587334257286605e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,4091,167,1.55 [1.28-1.88],1.019691189869224e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRG1,Leucine-rich alpha-2-glycoprotein,3684,142,3.04 [1.71-5.39],0.0001428117273007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,4255,175,2.59 [1.89-3.53],2.040870941910073e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP1,Prolow-density lipoprotein receptor-related protein 1,4212,172,1.83 [1.16-2.88],0.0091960373515539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,4233,173,2.37 [1.73-3.24],8.228266747359239e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,4131,169,0.62 [0.45-0.87],0.0053201477827936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,4283,174,3.69 [2.74-4.95],5.2322499596482456e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,4103,164,1.44 [1.23-1.70],1.0690241365655357e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,4208,170,3.81 [2.85-5.09],1.1322275909299442e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,4203,168,2.08 [1.63-2.67],4.868142483944897e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY9,T-lymphocyte surface antigen Ly-9,4180,169,2.43 [1.62-3.63],1.7067619528586914e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,4194,169,1.91 [1.40-2.62],5.382450794134611e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LYPD3,Ly6/PLAUR domain-containing protein 3,4193,171,1.82 [1.26-2.61],0.0013220114458638
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,4174,168,1.32 [1.09-1.60],0.0043685635573436
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAG,Myelin-associated glycoprotein,3584,138,0.63 [0.45-0.89],0.009162739288968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,3670,144,2.94 [2.12-4.08],1.0945302252698014e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,4238,174,4.00 [2.67-6.01],2.1674993993063427e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAP2,Microtubule-associated protein 2,3657,142,1.56 [1.17-2.09],0.0027033153580677
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MATN2,Matrilin-2,4235,170,1.95 [1.28-2.97],0.0019195567837668
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,4283,174,1.66 [1.36-2.01],4.1044983070860674e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MCAM,Cell surface glycoprotein MUC18,4246,171,2.19 [1.56-3.06],5.264971868759871e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,4194,169,1.41 [1.17-1.69],0.0003269617736731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,4225,173,1.97 [1.65-2.36],1.740714636287444e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,3670,144,2.34 [1.44-3.82],0.0006352021295138
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MENT,Protein MENT,3611,140,0.36 [0.19-0.67],0.0012237416159248
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEP1B,Meprin A subunit beta,4233,173,0.85 [0.76-0.95],0.002870291061083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MERTK,Tyrosine-protein kinase Mer,4281,174,2.94 [1.87-4.61],2.714298250959544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,3611,140,3.23 [2.08-5.02],1.730826019626846e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,4283,174,1.85 [1.37-2.51],6.842351128266759e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,4246,172,1.53 [1.19-1.96],0.0008447381040885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MILR1,Allergin-1,4131,169,1.57 [1.23-2.01],0.0002977260372293
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MLN,Promotilin,4226,172,1.23 [1.06-1.44],0.0082912985516745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP1,Interstitial collagenase,4091,161,1.33 [1.14-1.57],0.0004369715229292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,4222,170,1.79 [1.45-2.20],4.301569893113485e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,4237,175,1.64 [1.33-2.03],4.548199685006963e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP3,Stromelysin-1,4246,172,1.42 [1.12-1.80],0.0042103607765234
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,4147,167,2.45 [1.85-3.24],2.9856343772542136e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,4267,175,2.11 [1.51-2.94],1.0086433014954178e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRC1,Macrophage mannose receptor 1,3685,143,2.37 [1.42-3.95],0.0008926060831418
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLN,Mesothelin,4200,171,1.37 [1.12-1.68],0.0026207267921799
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSMB,Beta-microseminoprotein,4234,174,1.44 [1.20-1.72],6.646191881757823e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,4264,173,1.71 [1.31-2.24],0.0001015764683718
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,4101,164,1.96 [1.63-2.35],9.375669756121545e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYBPC1,"Myosin-binding protein C, slow-type",3670,144,1.37 [1.14-1.65],0.0007980343837682
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",3584,138,1.61 [1.31-1.96],4.058673909225135e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGK,N-acetyl-D-glucosamine kinase,3571,143,0.67 [0.50-0.89],0.0058556802291178
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,4238,174,5.20 [3.55-7.62],2.187521782799337e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCAN,Neurocan core protein,4264,173,0.63 [0.46-0.86],0.0038944785066957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,4223,172,3.32 [2.49-4.42],2.3046698266961227e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,3652,139,4.14 [2.86-5.99],4.5741972260202514e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,4267,175,4.44 [2.96-6.64],4.2908605423167313e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,4233,173,3.74 [2.75-5.09],3.4134060021626075e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,4238,174,2.61 [2.09-3.25],1.090194785066787e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,4088,163,2.98 [2.50-3.55],3.325776505153205e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,4238,174,0.37 [0.30-0.47],7.884336194477506e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,4281,174,4.22 [2.93-6.08],9.633326468178884e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,4194,169,4.74 [1.94-11.60],0.0006584798475162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGFR,Tumor necrosis factor receptor superfamily member 16,3670,144,1.65 [1.22-2.22],0.0012221893469139
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NHLRC3,NHL repeat-containing protein 3,3519,135,2.42 [1.43-4.10],0.0009686371153438
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NID1,Nidogen-1,4240,170,1.60 [1.13-2.26],0.008571156895762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,4246,172,2.12 [1.29-3.49],0.0029947146693209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",4101,164,1.73 [1.42-2.11],6.004792069725396e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS3,"Nitric oxide synthase, endothelial",4101,164,1.36 [1.10-1.69],0.0043080920726216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH1,Neurogenic locus notch homolog protein 1,4283,174,10.07 [4.74-21.40],1.958024682602244e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,3683,141,3.52 [1.98-6.28],1.98637070516078e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH3,Neurogenic locus notch homolog protein 3,4283,174,1.77 [1.25-2.51],0.0013111219251416
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,3632,140,4.43 [3.01-6.51],3.4353065858947123e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,4233,173,2.95 [2.30-3.78],1.822225484142692e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPPB,Natriuretic peptides B,4152,167,1.27 [1.16-1.39],3.8534490510066673e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,4267,175,1.96 [1.58-2.44],9.98180354528999e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRCAM,Neuronal cell adhesion molecule,4233,173,2.16 [1.47-3.18],9.065962294355422e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,4249,171,3.16 [2.02-4.94],4.886589703598548e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,3657,142,2.03 [1.49-2.78],7.488956251758484e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTF3,Neurotrophin-3,4226,172,1.56 [1.16-2.10],0.0030030990258055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,4233,173,1.33 [1.22-1.46],7.236428363498021e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,4262,175,2.21 [1.59-3.06],2.176050762112181e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,3668,142,1.98 [1.47-2.69],9.398970813328966e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,4246,172,2.74 [2.16-3.49],1.7818599517419656e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,4212,172,1.42 [1.11-1.81],0.0055026291230235
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,4235,170,2.75 [1.87-4.03],2.566521978440448e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,P4HB,Protein disulfide-isomerase,4202,173,1.59 [1.12-2.25],0.009318983024518
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,3634,138,2.68 [1.81-3.96],9.0736312268554e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,3657,142,2.67 [1.97-3.61],1.9216134697477972e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,4261,174,2.86 [1.80-4.56],8.821809270985139e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH17,Protocadherin-17,4233,173,1.71 [1.27-2.30],0.0004130759716271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,3652,139,2.01 [1.48-2.72],6.714052959272786e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDHB15,Protocadherin beta-15,3659,142,1.82 [1.34-2.48],0.0001230833960001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,4283,174,1.69 [1.21-2.34],0.0018124314579145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,4262,174,1.82 [1.43-2.32],1.3001118530198665e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,4212,172,3.74 [2.74-5.11],1.2029375319575596e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,4233,173,3.19 [2.16-4.70],4.617338878191939e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PEAR1,Platelet endothelial aggregation receptor 1,4283,174,2.95 [1.66-5.25],0.0002394325471942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PENK,Proenkephalin-A,3611,140,2.15 [1.45-3.20],0.000153666988685
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGA4,Pepsin A-4,3685,143,1.35 [1.13-1.62],0.0007985554250889
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,4281,174,4.57 [3.28-6.37],3.167588189796169e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGLYRP1,Peptidoglycan recognition protein 1,4266,174,1.75 [1.35-2.28],2.39579367481859e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHLDB1,Pleckstrin homology-like domain family B member 1,3652,139,1.95 [1.46-2.59],4.633427014067515e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,4194,169,3.15 [2.07-4.81],9.58649573196128e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,4179,171,1.63 [1.38-1.93],1.0665540403649342e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,4190,170,2.52 [1.93-3.28],6.436336737052237e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,4246,172,5.10 [3.82-6.82],3.553914954664088e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,4246,172,2.93 [2.14-4.01],1.671632958961874e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,4233,173,2.05 [1.58-2.64],4.1667880453886815e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,3670,144,4.46 [2.62-7.61],3.9770843186150186e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G10,Group 10 secretory phospholipase A2,4194,169,1.50 [1.19-1.89],0.0005349187553795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G15,Phospholipase A2 group XV,4238,174,2.01 [1.29-3.12],0.0019138622932641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,4246,172,0.46 [0.33-0.65],8.64773694894892e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,4207,170,4.96 [3.41-7.20],3.906234995989406e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",3657,142,0.55 [0.42-0.72],1.3440650066545978e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLG,Plasminogen,3587,138,2.53 [1.25-5.09],0.0096015008490742
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,4262,172,5.46 [3.79-7.86],6.9922157458614e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PODXL2,Podocalyxin-like protein 2,4238,174,2.47 [1.64-3.73],1.6251713373806964e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,3559,140,1.79 [1.38-2.31],8.289632661777638e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",4212,172,1.67 [1.29-2.16],9.785557534598155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,3668,142,1.81 [1.35-2.41],5.946825556935255e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PPY,Pancreatic prohormone,4221,173,1.20 [1.06-1.35],0.0028806196447808
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,3683,141,4.98 [3.22-7.72],6.116051208307159e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRCP,Lysosomal Pro-X carboxypeptidase,4261,174,2.02 [1.44-2.84],5.198636119195455e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PREB,Prolactin regulatory element-binding protein,4131,169,2.09 [1.50-2.92],1.4858812249201146e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,4226,170,4.89 [3.14-7.61],2.1427116692716293e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRG2,Bone marrow proteoglycan,3683,141,1.87 [1.42-2.46],9.116927510829934e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,4264,173,1.25 [1.08-1.46],0.0036395999555678
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRRT3,Proline-rich transmembrane protein 3,3579,143,1.94 [1.41-2.67],5.053663879358992e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS2,Trypsin-2,4246,171,1.28 [1.06-1.53],0.0087747734283898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS22,Brain-specific serine protease 4,3559,140,1.73 [1.25-2.39],0.0009234016287971
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,4224,173,2.08 [1.52-2.86],5.8132008165478585e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,4216,169,3.19 [2.39-4.25],2.468634283977944e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,4267,175,3.14 [1.94-5.09],3.2230792806929466e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,3658,141,4.71 [2.84-7.81],1.962510927032447e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,4194,169,1.47 [1.29-1.68],1.0942552683164946e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,4203,170,3.04 [2.35-3.94],4.482546159856148e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,4226,172,1.51 [1.19-1.90],0.000557956497623
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,4101,164,2.37 [1.70-3.31],3.539219995268723e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,3683,141,2.89 [1.48-5.63],0.0018238206365205
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRF,Receptor-type tyrosine-protein phosphatase F,4283,174,2.05 [1.33-3.17],0.0011390661034596
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,3652,139,1.64 [1.26-2.13],0.0002250238584982
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,4180,168,2.57 [1.94-3.40],3.6076415626391106e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTX3,Pentraxin-related protein PTX3,4226,172,1.85 [1.33-2.57],0.0002859923955153
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,4264,173,2.02 [1.52-2.68],1.257937902199545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,3553,138,1.38 [1.21-1.57],1.1841588314090384e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,QPCT,Glutaminyl-peptide cyclotransferase,4242,174,4.36 [2.75-6.91],3.5902849449360377e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,4226,172,0.57 [0.43-0.74],3.675501410776628e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,4249,171,1.85 [1.47-2.32],1.05467823980182e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,3668,142,2.26 [1.84-2.77],6.5626859542390625e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,4212,172,1.59 [1.37-1.84],1.6424889146023331e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP5,Retinol-binding protein 5,4212,172,1.33 [1.09-1.62],0.0048997546883763
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,3652,139,1.44 [1.18-1.76],0.0004268837801901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,4210,170,2.36 [1.97-2.84],4.187577307287875e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,4283,174,1.76 [1.47-2.11],7.87133452850422e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG3A,Regenerating islet-derived protein 3-alpha,4283,174,1.69 [1.42-2.01],3.3546479711283443e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,4235,170,2.78 [2.27-3.40],3.135641717648654e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,4246,172,3.59 [2.54-5.08],5.793111189654367e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,4233,173,1.76 [1.57-1.98],1.2576486599258472e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RETN,Resistin,4231,173,1.81 [1.41-2.34],4.867069661045807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,4264,173,2.85 [1.91-4.24],2.585353961027708e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,3685,143,4.48 [2.98-6.73],6.261471502218906e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE10,Inactive ribonuclease-like protein 10,3579,143,1.83 [1.43-2.34],1.3829673301119767e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,3550,136,4.28 [2.80-6.55],2.230739795151694e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,3654,141,2.07 [1.63-2.62],1.7229441986520111e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,4269,174,3.51 [2.75-4.47],5.9461398874331915e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,3579,143,4.13 [2.84-6.01],1.34004598499697e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,4233,173,2.01 [1.39-2.92],0.0002349619200586
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO1,R-spondin-1,4194,169,2.45 [1.68-3.58],3.5115790177411737e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,4267,175,3.01 [2.13-4.26],5.373538417455935e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTBDN,Retbindin,4212,172,1.95 [1.46-2.60],5.102202027341456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,4267,175,3.61 [2.58-5.06],8.28178833462527e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100A14,Protein S100-A14,3668,142,0.60 [0.43-0.85],0.0040401514702517
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,4152,167,1.43 [1.21-1.70],3.338261376109526e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,4264,173,4.81 [3.45-6.70],1.798338742011497e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB1,Scavenger receptor class B member 1,4101,164,1.34 [1.12-1.60],0.0016441846916456
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,4107,167,3.84 [3.01-4.91],3.0046822457996976e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF1,Scavenger receptor class F member 1,4283,174,1.79 [1.33-2.41],0.000111113400991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,4264,173,4.61 [3.46-6.15],1.8446932368010624e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,4250,175,4.66 [3.39-6.40],2.539502127240861e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,4235,170,1.81 [1.24-2.66],0.0023354940208692
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,4235,170,1.92 [1.49-2.47],4.073639216339978e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,4131,169,2.44 [1.93-3.08],9.035593187884205e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCN4B,Sodium channel subunit beta-4,3579,143,1.66 [1.23-2.23],0.0008295252144824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,3670,144,2.36 [1.47-3.77],0.0003427765689258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SDC4,Syndecan-4,4233,173,0.66 [0.51-0.86],0.0022032949602603
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEL1L,Protein sel-1 homolog 1,3579,143,1.92 [1.40-2.64],4.91857189678541e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SELE,E-selectin,4283,174,1.39 [1.09-1.76],0.0069093670214949
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA3F,Semaphorin-3F,4233,173,2.29 [1.46-3.59],0.0003139986022595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEMA7A,Semaphorin-7A,4273,174,2.47 [1.74-3.51],4.630012357467557e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN8,Septin-8,3648,141,2.53 [1.86-3.44],2.626527380659795e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINA6,Corticosteroid-binding globulin,3684,142,4.59 [1.85-11.38],0.0009860338642028
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINC1,Antithrombin-III,3674,141,3.95 [1.47-10.61],0.0064350745924637
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,3621,140,3.73 [2.13-6.52],4.112557738467928e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,3674,141,4.57 [2.03-10.28],0.000245650512544
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L,Seizure 6-like protein,4238,174,2.73 [1.83-4.08],9.03593568634782e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEZ6L2,Seizure 6-like protein 2,4212,172,2.25 [1.42-3.57],0.0005793357729846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,4182,169,2.02 [1.59-2.58],1.1364336317040436e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,3683,141,3.50 [2.51-4.88],1.5178290995470982e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC1,Sialoadhesin,4248,170,2.38 [1.79-3.16],2.3790850231209484e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,4226,172,2.60 [1.93-3.50],3.1494028767205723e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,4267,175,3.41 [2.40-4.85],7.344720139886067e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,4233,173,2.11 [1.35-3.32],0.0011409722314437
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,3579,143,1.53 [1.12-2.09],0.0069313550143893
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIRPB1,Signal-regulatory protein beta-1,4218,170,2.29 [1.78-2.96],2.1810877385359566e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,4131,169,1.46 [1.15-1.85],0.0019782046806046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF1,Signaling lymphocytic activation molecule,4131,169,1.58 [1.27-1.96],3.886682351477141e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF6,SLAM family member 6,4103,164,1.66 [1.22-2.26],0.0011134067578082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF7,SLAM family member 7,4226,172,1.50 [1.21-1.86],0.000253088721382
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLAMF8,SLAM family member 8,4103,164,1.57 [1.22-2.01],0.0004012001429765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,4101,164,1.76 [1.37-2.27],1.0804787830212457e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A5,Zinc transporter ZIP5,4226,172,1.49 [1.25-1.79],1.0339175394413432e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK2,SLIT and NTRK-like protein 2,4267,175,2.27 [1.65-3.14],5.662896695949668e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,4152,167,2.12 [1.51-2.97],1.4853765820473798e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,4267,175,3.04 [2.14-4.30],3.9033403272447356e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,4248,170,2.61 [1.99-3.44],5.91165572250775e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,4194,169,1.95 [1.60-2.37],2.8353164768326555e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,4103,164,2.70 [2.02-3.60],1.3578595795250804e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPARCL1,SPARC-like protein 1,4221,169,1.97 [1.24-3.14],0.0043114075736007
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,3670,144,1.94 [1.27-2.96],0.0021418675522636
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,4246,172,2.52 [2.07-3.06],1.7288279816147934e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,4226,172,2.39 [2.05-2.78],9.01228761947017e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK5,Serine protease inhibitor Kazal-type 5,4246,172,1.73 [1.20-2.49],0.0035458092009844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT1,Kunitz-type protease inhibitor 1,4235,172,2.20 [1.46-3.30],0.0001568534104939
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINT2,Kunitz-type protease inhibitor 2,4248,170,2.42 [1.80-3.24],3.966273115217784e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON1,Spondin-1,4235,170,3.15 [2.34-4.25],4.72752106106404e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,4218,172,3.13 [2.26-4.32],4.856375615237986e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPP1,Osteopontin,4276,174,1.54 [1.19-2.00],0.0009150927780107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPRR3,Small proline-rich protein 3,3657,142,1.37 [1.12-1.69],0.0027038011075577
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SRPX,Sushi repeat-containing protein SRPX,3670,144,2.64 [1.78-3.92],1.3907591054751157e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",4212,172,1.79 [1.43-2.23],2.650412590280727e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",4283,174,2.54 [1.67-3.86],1.2600040619062082e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,4264,173,2.13 [1.66-2.73],2.909150726944069e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC2,Stanniocalcin-2,4237,169,2.88 [1.67-4.94],0.000129469606161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD2,Sushi domain-containing protein 2,4246,172,2.27 [1.48-3.49],0.0001681727004311
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SUSD5,Sushi domain-containing protein 5,3595,139,2.11 [1.37-3.25],0.0007304994479515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TACSTD2,Tumor-associated calcium signal transducer 2,3746,154,3.52 [2.38-5.20],3.205326545435639e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,4212,172,2.96 [2.31-3.80],8.542245539478136e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,4276,174,2.39 [1.74-3.29],7.346693261078e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCOF1,Treacle protein,3670,144,1.81 [1.21-2.71],0.0039010998874236
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TEK,Angiopoietin-1 receptor,4238,174,2.38 [1.37-4.12],0.002026894226443
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TF,Serotransferrin,3684,142,3.69 [1.81-7.51],0.0003310424594271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,4226,172,1.65 [1.46-1.86],1.1269407595349361e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,4242,170,2.20 [1.87-2.60],2.6654033431612427e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,4207,169,2.14 [1.83-2.51],2.8544361515249506e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,4230,174,1.52 [1.22-1.89],0.0001749272448676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFA,Protransforming growth factor alpha,4226,172,1.84 [1.44-2.34],7.656930695397495e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFB1,Transforming growth factor beta-1 proprotein,4273,174,1.88 [1.42-2.50],1.1112684182502218e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,4238,174,2.96 [2.39-3.66],2.4556269568291625e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,4283,174,2.62 [1.81-3.79],3.241958035260943e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGOLN2,Trans-Golgi network integral membrane protein 2,3685,143,3.69 [2.32-5.86],3.470860611959762e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBD,Thrombomodulin,4233,173,2.44 [1.74-3.42],1.987954007613233e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,4246,172,1.69 [1.35-2.12],5.951457815815437e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THOP1,Thimet oligopeptidase,4220,173,0.53 [0.36-0.77],0.0008905823321292
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,4264,173,3.59 [2.48-5.21],1.3355550853081792e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP1,Metalloproteinase inhibitor 1,4176,168,3.28 [2.31-4.64],2.1853087245335245e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP2,Metalloproteinase inhibitor 2,3670,144,1.70 [1.19-2.42],0.0034806136377098
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TIMP4,Metalloproteinase inhibitor 4,4246,172,1.75 [1.30-2.35],0.0001917152248737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TINAGL1,Tubulointerstitial nephritis antigen-like,4227,173,2.86 [1.64-4.99],0.0002094588046523
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM132A,Transmembrane protein 132A,3579,143,0.70 [0.54-0.91],0.0068974919836346
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,3668,142,1.55 [1.15-2.08],0.0039070153985923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,3648,141,1.66 [1.18-2.35],0.0036625223571513
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,4212,172,1.32 [1.14-1.53],0.0002480493455724
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,4176,168,1.94 [1.35-2.77],0.0003243482053264
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNF,Tumor necrosis factor,4148,166,1.56 [1.22-1.98],0.0003093138981164
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,4194,169,2.83 [2.32-3.46],3.001927160399257e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,4194,169,1.63 [1.47-1.81],2.902720967504046e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,4281,174,2.98 [2.39-3.72],4.786994824061768e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,4226,170,2.72 [1.90-3.89],3.7647942065068994e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,4238,174,4.03 [3.09-5.25],5.35670373305044e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,4235,170,2.09 [1.57-2.77],3.732100888496899e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,4235,170,3.78 [2.92-4.88],4.336090987745375e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,4267,175,2.81 [2.24-3.54],1.2936606802061962e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,4246,172,4.75 [3.52-6.40],1.327292784705738e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,4246,172,1.74 [1.50-2.03],3.9686860356136893e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,4264,173,3.78 [2.54-5.62],5.330964493041778e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,4273,174,3.26 [2.54-4.19],2.203692651498838e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,4194,169,1.61 [1.32-1.97],3.811753843538797e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,4264,173,1.75 [1.36-2.24],1.1568147096924004e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,4194,169,2.29 [1.88-2.78],8.916398224111205e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,4248,170,5.26 [3.49-7.93],2.297412823320652e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,4279,174,1.76 [1.16-2.67],0.0075634280760397
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,3683,141,1.83 [1.25-2.68],0.0019458388460968
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNN,Tenascin-N,3683,141,1.73 [1.20-2.48],0.0031445178361529
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNR,Tenascin-R,4194,169,1.61 [1.19-2.19],0.0022614263316906
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TREML2,Trem-like transcript 2 protein,4246,172,1.65 [1.14-2.40],0.0080922058393804
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TXNDC5,Thioredoxin domain-containing protein 5,4264,173,1.30 [1.07-1.58],0.0074453607357938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",3559,140,1.66 [1.27-2.17],0.0002349782438282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,4194,169,3.80 [2.86-5.05],3.8744817674934734e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,4271,174,0.47 [0.38-0.57],3.3119431743238015e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,3657,142,1.68 [1.23-2.31],0.0012882271077505
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VASN,Vasorin,4169,168,2.91 [1.91-4.44],7.145837267783311e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAM1,Vascular cell adhesion protein 1,4245,171,3.66 [2.50-5.37],3.1891717435874916e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VCAN,Versican core protein,4264,173,1.79 [1.16-2.76],0.0084277452599859
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFA,Vascular endothelial growth factor A,4267,173,1.41 [1.14-1.76],0.001935856950145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,3559,140,2.80 [1.69-4.64],6.26406771352571e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,4273,173,2.67 [1.96-3.63],5.505979837953382e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,4212,172,1.73 [1.39-2.15],9.950582214735672e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,3659,142,1.93 [1.62-2.30],1.728742061689336e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,4237,169,3.16 [2.47-4.05],6.928134059029857e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSNL1,Visinin-like protein 1,3657,142,0.57 [0.38-0.85],0.006008251592935
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSTM1,V-set and transmembrane domain-containing protein 1,4101,164,1.51 [1.17-1.96],0.0017574763596201
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWA1,von Willebrand factor A domain-containing protein 1,4259,175,1.55 [1.13-2.12],0.0065164713854141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,4178,168,3.00 [2.23-4.03],3.8011045420792906e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,4260,174,1.31 [1.08-1.59],0.0063629892717002
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,4023,160,3.03 [2.46-3.73],3.5639833979118398e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",4235,170,2.09 [1.43-3.05],0.0001270741263583
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,4131,169,2.64 [2.06-3.38],2.0504285592915394e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XCL1,Lymphotactin,4267,175,1.38 [1.14-1.68],0.0011286145140216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,4258,173,3.40 [2.60-4.45],5.135369910002324e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,3657,142,4.68 [3.16-6.93],1.2968477171587712e-14
